Can human chorionic gonadotropin (hCG) and clomiphene citrate (Clomid) affect a male’s follicle‑stimulating hormone (FSH) and luteinizing hormone (LH) levels?

Effects of HCG and Clomiphene on Male FSH and LH Levels

Yes, both hCG and clomiphene citrate significantly affect FSH and LH levels in males, but in opposite directions: clomiphene increases both FSH and LH, while hCG (which mimics LH) does not directly increase endogenous FSH or LH and may actually suppress them through negative feedback.

Clomiphene Citrate Effects on Gonadotropins

Clomiphene citrate consistently and significantly increases both FSH and LH levels in men through its mechanism as a selective estrogen receptor modulator (SERM). 1

Mechanism of Action

• Clomiphene blocks estrogen receptors at the hypothalamic level, which removes negative feedback inhibition 2
• This blockade stimulates GnRH secretion, leading to increased pituitary gonadotropin (FSH and LH) release 2
• The drug initiates "a series of endocrine events culminating in a preovulatory gonadotropin surge" by increasing pituitary gonadotropin release 1

Magnitude of Effect

• A 2025 meta-analysis demonstrated that SERM therapy significantly improved LH (mean difference: 4.66 IU/L) and FSH (mean difference: 4.59 IU/L) compared to placebo 3
• In controlled trials, clomiphene 50 mg daily produced highly significant increases in both FSH and LH concentrations (P < 0.001) 4, 5
• These gonadotropin elevations occur alongside significant increases in testosterone and estradiol levels 4, 5

Clinical Considerations

• Lower baseline FSH levels predict greater response to clomiphene therapy 6
• Men with pre-treatment FSH <7 mIU/mL show better improvement in both hormonal parameters and sperm concentration 6
• The gonadotropin-stimulating effect is dose-dependent and reversible upon discontinuation 4, 5

Human Chorionic Gonadotropin (hCG) Effects on Gonadotropins

hCG does NOT increase endogenous FSH or LH levels; instead, it acts as an LH analog and may suppress endogenous gonadotropin production through negative feedback.

Mechanism of Action

• hCG is "essentially identical to the alpha sub-units of the human pituitary gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH)" in its alpha subunit structure 7
• It directly stimulates Leydig cells via LH/hCG receptors, bypassing the need for endogenous LH 8
• The resulting increase in testosterone production creates negative feedback at the hypothalamic-pituitary level, potentially suppressing endogenous FSH and LH secretion 9

Clinical Evidence

• In hypogonadotropic hypogonadism, hCG therapy is used specifically because these patients have LOW FSH and LH levels that need bypassing, not stimulation 2
• A 2019 rat study showed that hCG administration (100 IU/kg) increased testosterone, FSH, and LH concentrations, but this likely reflects the animal model's response rather than direct FSH/LH stimulation 8
• For secondary hypogonadism with fertility concerns, gonadotropin therapy (hCG with or without FSH) is standard because it maintains testosterone while preserving spermatogenesis 2

Combined Therapy: hCG Plus Clomiphene

When hCG and clomiphene are combined, the clomiphene component drives the increase in endogenous FSH and LH, while hCG provides direct testicular stimulation.

• A 2021 prospective study of combined hCG + clomiphene citrate (25 mg daily) in male hypogonadotropic hypogonadism showed significant improvements in testosterone and clinical features 10
• The combination may neutralize some negative effects: clomiphene's gonadotropin-stimulating action can counteract hCG-induced suppression of endogenous gonadotropins 8
• In a 2025 meta-analysis, testosterone levels were significantly higher with SERM therapy (158 ng/dL) and combined SERM + hCG (153 ng/dL) compared to hCG alone (134 ng/dL) 3

Critical Clinical Pitfalls

Avoid These Common Errors:

• Do not assume hCG will increase measured FSH/LH levels on laboratory testing—it will not, and may actually suppress them 9
• Do not use testosterone therapy in men seeking fertility—it suppresses FSH and LH, unlike clomiphene or hCG 2
• In men with adult-onset idiopathic hypogonadotropic hypogonadism, consider a trial of clomiphene alone before adding hCG, as select patients respond to clomiphene monotherapy 11
• Men with baseline FSH >7 mIU/mL show diminishing efficacy from clomiphene treatment 6

Monitoring Considerations:

• When using clomiphene, expect FSH and LH to rise significantly within 3 months 5, 6
• When using hCG alone, do not expect endogenous FSH/LH elevation—monitor testosterone and clinical response instead 9
• Combined therapy requires monitoring both gonadotropins (from clomiphene effect) and testosterone (from both agents) 10